TheThis experimentalgroundbreaking natureachievement ofhighlights thisthe treatmentremarkable raisespotential significantof concernspersonalized aboutgene long-termediting safetyto andrevolutionize efficacymedicine. WithoutThe comprehensiveswift long-termdevelopment studies,time theand riskssuccessful ofimplementation unintendedprove that custom genetic changestreatments remaincan unknown,be andboth thefeasible highand costpractical, ofpotentially personalizedoffering treatmentshope couldto createmillions accessibilityaffected barriersby forrare manygenetic patientsdisorders who needcurrently themhave no viable treatment options.
The experimental nature of this treatment raises significant concerns about long-term safety and efficacy. Without comprehensive long-term studies, the risks of unintended genetic changes remain unknown, and the high cost of personalized treatments could create accessibility barriers for many patients who need them.
There's a 50% chance that at least 40 gene-edited babies will have been born worldwide by the end of 2029, according to the Metaculus prediction community.